AHA GUIDELINES Bundle (free trial)

2017 Update Incorporated - Valvular Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/362033

Contents of this Issue

Navigation

Page 34 of 63

35 Valve Hemodynamics a Hemodynamic Consequences Symptoms No or trace TR None None or in relation to other le heart or pulmonary/ pulmonary vascular disease Mild TR: • Central jet area <5.0 cm 2 • Vena contracta width not defined • Continuous wave (CW) jet density and contour: soft and parabolic • Hepatic vein flow: systolic dominance Moderate TR: • Central jet area 5–10 cm 2 • Vena contracta width not defined but <0.70 cm • CW jet density and contour: dense, variable contour • Hepatic vein flow: systolic blunting Mild TR: • RV/RA/IVC size normal Moderate TR: • No RV enlargement • No or mild right atrium (RA) enlargement • No or mild IVC enlargement with normal respirophasic variation • Normal RA pressure None or in relation to other le heart or pulmonary/ pulmonary vascular disease • Central jet area >10.0 cm 2 • Vena contracta width >0.7 cm • CW jet density and contour: dense, triangular with early peak • Hepatic vein flow: systolic reversal • RV/RA/IVC dilated with decreased IVC respirophasic variation • Elevated RA pressure with "c-V" wave • Diastolic interventricular septal flattening may be present None, or in relation to other le heart or pulmonary/ pulmonary vascular disease • Central jet area >10.0 cm 2 • Vena contracta width >0.70 cm • CW jet density and contour: dense, triangular with early peak • Hepatic vein flow: systolic reversal • RV/RA/IVC dilated with decreased IVC respirophasic variation • Elevated RA pressure with "c-V" wave • Diastolic interventricular septal flattening • Reduced RV systolic function in late phase Fatigue, palpitations, dyspnea, abdominal bloating, anorexia, edema a Several valve hemodynamic criteria are provided for assessment of severity of TR, but not all criteria for each category will necessarily be present in every patient. Categorization of severity of TR as mild, moderate, or severe also depends on image quality and integration of these parameters with clinical findings.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - 2017 Update Incorporated - Valvular Heart Disease